Investment case
Our diversified business model and growth strategy enables us to achieve sustainable growth and value creation across the healthcare sector by leveraging our competitive advantages.
Our strong investment case was demonstrated during the year through our agile response and resilience in the face of the coronavirus (COVID-19) pandemic. Despite the challenges faced, we were able to leverage our diversified business units to ensure we met our clients' service level agreements.
Health administration business
One of the largest health administration businesses in the South African healthcare sector.
3.9 million under management
An established track record as a medical scheme administrator – 3.9 million lives under management (39% of market share).
Market leader in managed care
An integrated healthcare business and market leader in managed care.
13 million scripts dispensed per annum
Approximately 13 million scripts dispensed per annum – public sector makes up 80% of the total prescriptions dispensed.
Largest distributor of chronic medicine
The largest distributor of chronic medicine to public hospitals and clinics.
Pharmaceutical business contributed 53% in revenue
A diversified healthcare business with growing exposure across the healthcare value chain in South Africa – our pharmaceutical business contributed 53% in revenue.
Diversification
Diversification makes us more sustainable in a changing healthcare environment.
Group to optimise healthcare costs
Our business model enables the Group to optimise healthcare costs to deliver on our mission.
Competent and
experienced management
Experienced and empowered leadership team with healthcare expertise.
Market-leading intellectual capital with clinical, actuarial, data analytics and health intelligence competence and capabilities.
Data capabilities support our strategy to eliminate inefficiencies within the healthcare industry and optimise the healthcare value chain.
Long-term incentives are in place for strategic employees
Click on the years to view more information.
OUR MILESTONES
AfroCentric incorporated and listed on the JSE
Acquires AfroCentric Health Group (80% effective interest)
Increased interest in AfroCentric Health to 94.1%
Helios IT Solutions (now AfroCentric Technologies) acquired 51% of Allegra
Acquires South African licence of documentbased care back and neck rehabilitation programme through its acquisition of Klinnika
Acquires
100% of Pharmacy Direct, 100% of Curasana and 26% of Activo Health
Sanlam acquires 28.7% of AfroCentric Healthcare Assets
Awarded South African Police Service medical aid (POLMED) scheme contract
Acquires
100% of Wellness Odyssey and 51% of The Cheese Has Moved
Amalgamation of Bonitas and Liberty add 125 000 lives to our care
Pharmacy Direct secures further contracts for the delivery of chronic medicine to public sector patients, increasing footprint to seven South African provinces
Acquires
51% of EssentialMed
80% of Scriptpharm Risk Management
70% of MMed Distribution
ADS acquires 51% Of Tendahealth
COMMED merges with Bonitas
Awarded Hosmed Contract
Pharmacy Direct awarded Department of Health central chronic medicine dispensing and distribution contracts
Acquires
remaining 74% of Activo Health
82.8% OF PHA
100% of Sanlam Health (renamed AfroCentric Integrated Health Administrators)
Additional 25% of Associated Fund Administrators Botswana
Medshield Hospital and Fraud Management Bonitas Actuarial Services
Hosmed Medicine Management
POLMED Contracts Scriptpharm for chronic medicine management
Acquires
Remaining 17.2% of PHA
Additional 17% of TCHM
ACT Healthcare Assets acquires remaining 20% of Scriptpharm Risk Management
Medscheme wins contract to administer MEDiPOS Medical Scheme
ACT Healthcare Assets acquires DENIS Group
Medscheme awarded the Government Employees Medical Scheme managed care contract
AfroCentric FastPulse concludes contract to provide COVID-19 occupational health and safety support for the Western Cape’s Economic Development and Tourism Department
Activo Health acquires Exeltis SA (the holding company of Forrester Pharma and Lamar International)
Hosted SA Healthcare Industry Summit 2022.
AfroCentric incorporated and listed on the JSE
Acquires AfroCentric Health Group (80% effective interest)
Increased interest in AfroCentric Health to 94.1%
Helios IT Solutions (now AfroCentric Technologies) acquired 51% of Allegra
Acquires South African licence of documentbased care back and neck rehabilitation programme through its acquisition of Klinnika
Acquires
100% of Pharmacy Direct, 100% of Curasana and 26% of Activo Health
Sanlam acquires 28.7% of AfroCentric Healthcare Assets
Awarded South African Police Service medical aid (POLMED) scheme contract
Acquires
100% of Wellness Odyssey and 51% of The Cheese Has Moved
Amalgamation of Bonitas and Liberty add 125 000 lives to our care
Pharmacy Direct secures further contracts for the delivery of chronic medicine to public sector patients, increasing footprint to seven South African provinces
Acquires
51% of EssentialMed
80% of Scriptpharm Risk Management
70% of MMed Distribution
ADS acquires 51% Of Tendahealth
COMMED merges with Bonitas
Awarded Hosmed Contract
Pharmacy Direct awarded Department of Health central chronic medicine dispensing and distribution contracts
Acquires
remaining 74% of Activo Health
82.8% OF PHA
100% of Sanlam Health (renamed AfroCentric Integrated Health Administrators)
Additional 25% of Associated Fund Administrators Botswana
Medshield Hospital and Fraud Management Bonitas Actuarial Services
Hosmed Medicine Management
POLMED Contracts Scriptpharm for chronic medicine management
Acquires
Remaining 17.2% of PHA
Additional 17% of TCHM
ACT Healthcare Assets acquires remaining 20% of Scriptpharm Risk Management
Medscheme wins contract to administer MEDiPOS Medical Scheme
ACT Healthcare Assets acquires DENIS Group
Medscheme awarded the Government Employees Medical Scheme managed care contract
AfroCentric FastPulse concludes contract to provide COVID-19 occupational health and safety support for the Western Cape’s Economic Development and Tourism Department
Activo Health acquires Exeltis SA (the holding company of Forrester Pharma and Lamar International)
SA Healthcare Industry Summit 2022.